• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

敲低真核翻译起始因子 3 亚基 D(eIF3D)抑制急性髓系白血病细胞的增殖。

Knockdown of eukaryotic translation initiation factor 3 subunit D (eIF3D) inhibits proliferation of acute myeloid leukemia cells.

机构信息

Department of Hematology, Liaocheng People's Hospital, Liaocheng, Shandong, 252000, People's Republic of China.

School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310058, People's Republic of China.

出版信息

Mol Cell Biochem. 2018 Jan;438(1-2):191-198. doi: 10.1007/s11010-017-3127-5. Epub 2017 Aug 12.

DOI:10.1007/s11010-017-3127-5
PMID:28801778
Abstract

Various eukaryotic translation initiation factors (eIFs) have been implicated in carcinoma development. Eukaryotic translation initiation factor 3 subunit D (eIF3D) has recently been shown to regulate the growth of several types of human cancer cells. However, the function of eIF3D in acute myeloid leukemia (AML) remains unclear. In this study, we investigated the expression of eIF3D in three AML cell lines and a lymphoblast cell line, and found that eIF3D was expressed in all four leukemia cell lines. To explore the role of eIF3D in AML cell proliferation, lentivirus-mediated RNA interference was applied to knock down the expression of eIF3D in U937 cells. The expression of eIF3D was significantly downregulated in U937 cells after eIF3D knockdown, as confirmed by quantitative real-time PCR (qRT-PCR) and Western blot analysis. Knockdown of eIF3D significantly inhibited proliferation of U937 cells. Furthermore, flow cytometry analysis revealed that eIF3D silencing induced cell cycle arrest at the G2/M phase, ultimately leading to apoptosis. Our results indicate that eIF3D plays a key role in the proliferation of AML cells, and suggest that eIF3D silencing might be a potential therapeutic strategy for leukemia.

摘要

各种真核翻译起始因子(eIFs)已被牵涉到癌的发展中。真核翻译起始因子 3 亚基 D(eIF3D)最近被证明可以调节几种类型的人类癌细胞的生长。然而,eIF3D 在急性髓系白血病(AML)中的功能仍不清楚。在这项研究中,我们研究了 eIF3D 在三个 AML 细胞系和一个淋巴母细胞系中的表达,发现 eIF3D 在所有四个白血病细胞系中均有表达。为了探讨 eIF3D 在 AML 细胞增殖中的作用,我们应用慢病毒介导的 RNA 干扰技术敲低了 U937 细胞中 eIF3D 的表达。定量实时 PCR(qRT-PCR)和 Western blot 分析证实,eIF3D 敲低后 U937 细胞中 eIF3D 的表达显著下调。eIF3D 敲低显著抑制了 U937 细胞的增殖。此外,流式细胞术分析显示,eIF3D 沉默诱导细胞周期停滞在 G2/M 期,最终导致细胞凋亡。我们的结果表明,eIF3D 在 AML 细胞的增殖中起着关键作用,并提示 eIF3D 沉默可能是白血病的一种潜在治疗策略。

相似文献

1
Knockdown of eukaryotic translation initiation factor 3 subunit D (eIF3D) inhibits proliferation of acute myeloid leukemia cells.敲低真核翻译起始因子 3 亚基 D(eIF3D)抑制急性髓系白血病细胞的增殖。
Mol Cell Biochem. 2018 Jan;438(1-2):191-198. doi: 10.1007/s11010-017-3127-5. Epub 2017 Aug 12.
2
Lentivirus-mediated knockdown of eukaryotic translation initiation factor 3 subunit D inhibits proliferation of HCT116 colon cancer cells.慢病毒介导的真核翻译起始因子3亚基D敲低抑制HCT116结肠癌细胞的增殖。
Biosci Rep. 2014 Dec 12;34(6):e00161. doi: 10.1042/BSR20140078.
3
Knockdown of EIF3D suppresses proliferation of human melanoma cells through G2/M phase arrest.敲低EIF3D通过G2/M期阻滞抑制人黑色素瘤细胞的增殖。
Biotechnol Appl Biochem. 2015 Sep-Oct;62(5):615-20. doi: 10.1002/bab.1305. Epub 2015 Jan 12.
4
Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer.敲低真核生物翻译起始因子3d(eIF3d)通过使非小细胞肺癌细胞阻滞于G2/M期来抑制细胞增殖。
Med Oncol. 2015 Jul;32(7):183. doi: 10.1007/s12032-015-0625-8. Epub 2015 May 26.
5
RNAi-Mediated Silencing of EIF3D Alleviates Proliferation and Migration of Glioma U251 and U87MG Cells.RNA干扰介导的EIF3D沉默减轻胶质瘤U251和U87MG细胞的增殖和迁移
Chem Biol Drug Des. 2015 Oct;86(4):715-22. doi: 10.1111/cbdd.12542. Epub 2015 Jul 28.
6
Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/β-catenin signaling pathway.敲低真核生物翻译起始因子3D(eIF3D)可通过抑制Wnt/β-连环蛋白信号通路来抑制乳腺癌细胞的增殖和侵袭。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):10420-7. eCollection 2015.
7
EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling.EIF3D基因沉默通过下调细胞周期蛋白B1/周期蛋白依赖性激酶1信号通路诱导G2/M期阻滞,从而抑制肾细胞癌的肿瘤发生。
Int J Oncol. 2016 Jun;48(6):2580-90. doi: 10.3892/ijo.2016.3459. Epub 2016 Mar 28.
8
shRNA-mediated RPS15A silencing inhibits U937 acute myeloid leukemia cell proliferation and enhances apoptosis.短发夹RNA介导的核糖体蛋白S15A沉默抑制U937急性髓系白血病细胞增殖并增强凋亡。
Mol Med Rep. 2016 May;13(5):4400-6. doi: 10.3892/mmr.2016.5064. Epub 2016 Mar 30.
9
Reduced eIF3d accelerates HIV disease progression by attenuating CD8+ T cell function.eIF3d 的减少通过削弱 CD8+T 细胞功能加速 HIV 疾病进展。
J Transl Med. 2019 May 22;17(1):167. doi: 10.1186/s12967-019-1925-0.
10
The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.EIF3D的致癌作用与前列腺癌中细胞周期进程加快和运动性增加有关。
Med Oncol. 2015 Jul;32(7):518. doi: 10.1007/s12032-015-0518-x. Epub 2015 Jun 3.

引用本文的文献

1
A genetic screen in Drosophila uncovers the multifaceted properties of the NUP98-HOXA9 oncogene.果蝇中的遗传筛选揭示了 NUP98-HOXA9 癌基因的多方面特性。
PLoS Genet. 2021 Aug 12;17(8):e1009730. doi: 10.1371/journal.pgen.1009730. eCollection 2021 Aug.
2
LINC01420 RNA structure and influence on cell physiology.LINC01420 RNA 结构及其对细胞生理学的影响。
BMC Genomics. 2019 May 8;20(Suppl 3):298. doi: 10.1186/s12864-019-5538-z.
3
Overexpression of in Lung Adenocarcinoma Is a New Independent Prognostic Marker of Poor Survival.

本文引用的文献

1
eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation.真核生物翻译起始因子3d(eIF3d)是一种mRNA帽结合蛋白,是特殊翻译起始所必需的。
Nature. 2016 Aug 4;536(7614):96-9. doi: 10.1038/nature18954. Epub 2016 Jul 27.
2
Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer.敲低真核生物翻译起始因子3d(eIF3d)通过使非小细胞肺癌细胞阻滞于G2/M期来抑制细胞增殖。
Med Oncol. 2015 Jul;32(7):183. doi: 10.1007/s12032-015-0625-8. Epub 2015 May 26.
3
eIF3 targets cell-proliferation messenger RNAs for translational activation or repression.
肺腺癌中 过表达是新的独立预后不良的生存标志物。
Dis Markers. 2019 Dec 7;2019:6019637. doi: 10.1155/2019/6019637. eCollection 2019.
4
EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.EIF3D 通过与 GRP78 相互作用并抑制其降解来促进肾细胞癌对舒尼替尼的耐药性。
EBioMedicine. 2019 Nov;49:189-201. doi: 10.1016/j.ebiom.2019.10.030. Epub 2019 Oct 26.
5
RNA-binding proteins in hematopoiesis and hematological malignancy.RNA 结合蛋白在造血和血液系统恶性肿瘤中的作用。
Blood. 2019 May 30;133(22):2365-2373. doi: 10.1182/blood-2018-10-839985. Epub 2019 Apr 9.
真核起始因子3(eIF3)靶向细胞增殖信使核糖核酸以进行翻译激活或抑制。
Nature. 2015 Jun 4;522(7554):111-4. doi: 10.1038/nature14267. Epub 2015 Apr 6.
4
Knockdown of PSF1 expression inhibits cell proliferation in lung cancer cells in vitro.PSF1表达的敲低抑制体外肺癌细胞的增殖。
Tumour Biol. 2015 Mar;36(3):2163-8. doi: 10.1007/s13277-014-2826-8. Epub 2014 Nov 15.
5
Lentivirus-mediated knockdown of eukaryotic translation initiation factor 3 subunit D inhibits proliferation of HCT116 colon cancer cells.慢病毒介导的真核翻译起始因子3亚基D敲低抑制HCT116结肠癌细胞的增殖。
Biosci Rep. 2014 Dec 12;34(6):e00161. doi: 10.1042/BSR20140078.
6
Knockdown of EIF3D suppresses proliferation of human melanoma cells through G2/M phase arrest.敲低EIF3D通过G2/M期阻滞抑制人黑色素瘤细胞的增殖。
Biotechnol Appl Biochem. 2015 Sep-Oct;62(5):615-20. doi: 10.1002/bab.1305. Epub 2015 Jan 12.
7
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
8
Eukaryotic translation initiation factors in cancer development and progression.真核翻译起始因子在癌症发生发展中的作用。
Cancer Lett. 2013 Oct 28;340(1):9-21. doi: 10.1016/j.canlet.2013.06.019. Epub 2013 Jul 2.
9
Acute myeloid leukaemia in adults.成人急性髓系白血病。
Lancet. 2013 Feb 9;381(9865):484-95. doi: 10.1016/S0140-6736(12)61727-9.
10
Can we improve outcomes in patients with acute myelogenous leukemia? Incorporating HDAC inhibitors into front-line therapy.我们能否改善急性髓系白血病患者的预后?将 HDAC 抑制剂纳入一线治疗。
Best Pract Res Clin Haematol. 2012 Dec;25(4):427-35. doi: 10.1016/j.beha.2012.10.005. Epub 2012 Oct 25.